Optimal global spending for group A Streptococcus vaccine research and development

Group A Streptococcus (Strep A) leads to 600,000 deaths and 600 million cases of pharyngitis annually. Although long a promising target for vaccine development, how much funding should be allocated to develop a Strep A vaccine is unclear. We aim to calculate the optimal amount of global spending for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tortorice, Daniel, Ferranna, Maddalena, Bloom, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125865/
https://www.ncbi.nlm.nih.gov/pubmed/37185380
http://dx.doi.org/10.1038/s41541-023-00646-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125865/
https://www.ncbi.nlm.nih.gov/pubmed/37185380
http://dx.doi.org/10.1038/s41541-023-00646-6

Ejemplares similares